Please assess the completion status of the following clinical trial:

Trial Title: 24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The patient is suffering from XFG (if the patient has bilateral XFG, both eyes will be treated, but the worse eye will be selected for the statistical analysis)~* Patient is older than 39 years and younger than 85 years~* Patient is able and willing to participate in the study for the whole duration of the follow up. Will sign the consent form.~* At screening the untreated IOP at 10:00 (± 1 hr) is greater than 25 mm Hg and lower than 40 mm Hg~* After bimatoprost run-in therapy the treated IOP at 10:00 (± 1 hr) is greater than 19 mm Hg

- Gender: ALL
- Minimum Age: 39 Years
- Maximum Age: 81 Years
- Healthy Volunteers: f

Study Arms:
- Bimatoprost/Timolol AM therapy (Type: ACTIVE_COMPARATOR): None
- Bimatoprost/Timolol PM therapy (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).